Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

Publication | Closed Access

DOI

272

Citations

References

2004

Year

John H. Krystal, Walid Abi‐Saab, Edward Perry, Deepak Cyril D’Souza, Nianjin Liu, Ralitza Gueorguieva, Lisa McDougall, Tracy Hunsberger, Ayşenil Belger, Louise R. Levine,

Psychopharmacology

PsychiatryBrain FunctionMedicineDisruptive EffectsPsychopharmacologyMemoryNeuropharmacologyWorking MemoryPreliminary EvidenceNeuroscienceCognitive NeuroscienceNeurochemistrySocial SciencesHealthy Human Subjects